ICT01 2588
Alternative Names: ICT 012588; ICT 1&2; ICT01; Smart BombLatest Information Update: 28 Sep 2025
At a glance
- Originator University of Bradford Institute of Cancer Therapeutics
- Developer Incanthera
- Class Antineoplastics; Colchicum alkaloids; Drug conjugates; Peptides
- Mechanism of Action Vascular disrupting agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer
Most Recent Events
- 28 Sep 2025 No recent reports of development identified for preclinical development in Breast-cancer in United Kingdom (Parenteral)
- 28 Sep 2025 No recent reports of development identified for preclinical development in Colorectal-cancer in United Kingdom (Parenteral)
- 28 Sep 2025 No recent reports of development identified for preclinical development in Lung-cancer in United Kingdom (Parenteral)